BDX
Becton, Dickinson and Company · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 160 | -1 | 195.22M | $30.73B | +7 | −7 |
| Q1 2026 | 163 | -3 | 192.59M | $31.06B | +5 | −9 |
| Q4 2025 | 165 | -1 | 211.71M | $41.08B | +1 | −1 |
| Q3 2025 | 24 | 0 | 114.22M | $21.37B | +1 | −2 |
| Q2 2025 | 22 | 0 | 103.94M | $17.90B | +2 | −2 |
| Q1 2025 | 19 | 0 | 42.24M | $9.67B | +1 | −1 |
| Q4 2024 | 19 | 0 | 42.40M | $9.62B | +1 | −1 |
| Q3 2024 | 18 | -1 | 28.02M | $6.75B | — | −1 |
| Q2 2024 | 19 | — | 28.10M | $6.56B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.74M | — | $2.51B | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (passive) | 6.17M | — | $1.44B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 3.20M | — | $747.58M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.61M | — | $377.44M | 0.3% | n/c | 1 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.47M | — | $342.66M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 1.11M | — | $260.01M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 7 | Marshall Wace ✦ | 784.44K | — | $183.33M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 530.16K | — | $123.90M | 0.3% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 498.56K | — | $116.52M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 484.19K | — | $113.16M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 393.81K | — | $92.04M | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 306.09K | — | $71.54M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 302.40K | — | $70.67M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 258.25K | — | $59.89M | 0.1% | n/c | 1 | SEC ↗ ×4 |
| 15 | Bridgewater Associates ✦ | 210.34K | — | $49.16M | 0.3% | n/c | 1 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 10.49K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 4.90K | — | $1.14M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 1.99K | — | $465,220 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Dodge & Cox ✦ | 980 | — | $229,036 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,452 holders, 258.69M shares, $38.42B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 76 sh · $13,961
Officer · 165 sh · $31,101
Officer, Director · 4.15K sh · $768,120
Officer · 2.44K sh · $440,888
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology